These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33308377)

  • 1. A Preliminary Study of miR-144 Inhibiting the Stemness of Colon Cancer Stem Cells by Targeting Krüppel-Like Factor 4.
    Qiu Z; Tu L; Hu X; Zhou Z; Lin Y; Ye L; Cui C
    J Biomed Nanotechnol; 2020 Jul; 16(7):1102-1109. PubMed ID: 33308377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-532 promotes colorectal cancer invasion and metastasis by targeting NKD1.
    Song X; Wu R; Tao Q; Zhao L; Ji Z
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):52-55. PubMed ID: 31472047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
    Hongdan L; Feng L
    Biochem Biophys Res Commun; 2018 Feb; 496(2):302-308. PubMed ID: 29307822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis.
    Zhu X; Shen Z; Man D; Ruan H; Huang S
    Comput Math Methods Med; 2020; 2020():8209504. PubMed ID: 32952601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4.
    Tang W; Zhu Y; Gao J; Fu J; Liu C; Liu Y; Song C; Zhu S; Leng Y; Wang G; Chen W; Du P; Huang S; Zhou X; Kang J; Cui L
    Br J Cancer; 2014 Jan; 110(2):450-8. PubMed ID: 24281002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-10b controls the metastasis and proliferation of colorectal cancer cells by regulating Krüppel-like factor 4.
    Xie Y; Zhao J; Liang Y; Chen M; Luo Y; Cui X; Jiang B; Peng L; Wang X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1722-1729. PubMed ID: 31032663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29a-KLF4 signaling inhibits breast tumor initiation by regulating cancer stem cells.
    Zhao Q; Shang Y; Lü J; Liu Y; Wang T; Li D; Li J; Lu Y; Wang Z; Yu Z
    Int Immunopharmacol; 2024 Mar; 130():111797. PubMed ID: 38442582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
    Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
    Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4.
    Lv H; Zhang Z; Wang Y; Li C; Gong W; Wang X
    Oncol Res; 2016; 23(6):283-90. PubMed ID: 27131314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
    Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN
    Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.
    Chen HY; Lin YM; Chung HC; Lang YD; Lin CJ; Huang J; Wang WC; Lin FM; Chen Z; Huang HD; Shyy JY; Liang JT; Chen RH
    Cancer Res; 2012 Jul; 72(14):3631-41. PubMed ID: 22593189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
    Zeng M; Zhu L; Li L; Kang C
    Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
    Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
    PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
    Qin Y; Chen X; Liu Z; Tian X; Huo Z
    Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.